Found: 9
Select item for more details and to access through your institution.
Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9081, doi. 10.3390/ijms21239081
- By:
- Publication type:
- Article
Incidence of upper extremity deep vein thrombosis in the retrosternal reconstruction after esophagectomy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Functional benefits of the double flap technique after proximal gastrectomy for gastric cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
- Published in:
- Carcinogenesis, 2021, v. 42, n. 1, p. 21, doi. 10.1093/carcin/bgaa123
- By:
- Publication type:
- Article
KRT17 as a prognostic biomarker for stage II colorectal cancer.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 5, p. 591, doi. 10.1093/carcin/bgz192
- By:
- Publication type:
- Article
PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-81667-w
- By:
- Publication type:
- Article
Down-regulation of stimulator of interferon genes (STING) expression and CD8<sup>+</sup> T-cell infiltration depending on HER2 heterogeneity in HER2-positive gastric cancer.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 6, p. 878, doi. 10.1007/s10120-023-01417-x
- By:
- Publication type:
- Article
Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 1, p. 60, doi. 10.1007/s10120-020-01094-0
- By:
- Publication type:
- Article
Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma.
- Published in:
- Oncology Letters, 2021, v. 21, n. 6, p. N.PAG, doi. 10.3892/ol.2021.12706
- By:
- Publication type:
- Article